Indefinite Delivery Contract 36E79720D0049
Award Date
11/16/20
Last Date to Order
11/15/25
Federal Agency
National Acquisition Center
Awardee
Xlcare Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $143,284,854.50 and a period of performance from September 24, 2020 to September 23, 2025, with a one-year base period and four one-year option periods.
The contract is for the supply of...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The IDC has a potential value of $18,554,214.00 and a period of performance from May 24, 2021 to May 23, 2022, with four one-year option periods.
Under this IDC, Xlcare Pharmaceuticals will supply levetiracetam tablets to the VA,...
The National Acquisition Center, a civilian agency of the U.S. federal government, has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $761,850 contract is for the supply of lacosamide injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a one-year base period with four one-year option periods.
This IDC was competitively awarded without...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026.
The contract will supply aripiprazole tablets in various package sizes to the VA,...
The indefinite delivery contract (IDC) 36E79721D0051 was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is also certified as an economically disadvantaged woman-owned small business. The contract, which has a ceiling value of $1,423,620.00, is for the supply of dutasteride capsules to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS).
The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Avkare, LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $1,244,773.20 and a performance period from July 15, 2024 to July 14, 2025, with four one-year option periods.
The contract aims to provide a wide range of pharmaceutical and medical products to support the healthcare missions of the Department of Veterans Affairs (VA), Department...
The Indefinite Delivery Contract (IDC) with award ID 36E79725D0002 was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc. for the provision of a wide range of branded and generic pharmaceutical products and services. This single-award IDC has a ceiling value of $4,792,297.44 and a period of performance running through December 19, 2025.
Exelan Pharmaceuticals, a foreign-owned for-profit pharmaceutical company, will supply prescription...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc. The single-award contract has a ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025, with four one-year option periods.
The contract is for the supply of Topiramate tablets in various dosages and package sizes to the VA, Department of Defense, Bureau of Prisons,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...